The Bob Harrington Show

In this annual tradition, Drs Harrington and Gibson discuss their picks for the top cardiology trials of the year, covering PCSK9 inhibitors, anti-inflammatory and anthithrombotic drugs, and PCI.

Drs Harrington and Kesselheim discuss the varied reasons why prescription drugs are so pricey and whether policies can interrupt this alarming trend.

Dr Califf talks about his new role at Verily and how data mining and data sharing could reduce disparities in care and improve patient outcomes.

From being critiqued by Bernie Sanders to the controversial Duchenne drug approval decision, Dr Califf recounts his experiences as FDA commissioner.

The Veterans Health Administration is the largest integrated healthcare system in the US with a common EHR. Dr Harrington learns the advantages for cardiology practice and research.

Why are only 13% of cardiologists women? Drs Harrington and Duvernoy discuss results from the recent ACC lifestyle survey and strategies for making cardiology 'a more human place.'

Drs Harrington and Douglas discuss pay disparities for women in cardiology and the importance of leveling the playing field.

Drs Harrington and Butte discuss the overwhelming amount of data generated in contemporary healthcare and how it can be harnessed to deliver precision medicine.

Drs Harrington and Gibson give their annual review of the highs and lows in medicine with a focus on cardiology.

Dr Harrington interviews Dr John Brush about his exploration of cognitive psychology (behavioral economics) and how it can improve physician decision-making.